Fortis Healthcare Toekomstige groei

Future criteriumcontroles 4/6

Fortis Healthcare zal naar verwachting groeien in winst en omzet met respectievelijk 24.1% en 12.6% per jaar. De winst per aandeel zal naar verwachting groeien met 24.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.4% zijn.

Belangrijke informatie

24.1%

Groei van de winst

24.5%

Groei van de winst per aandeel

Healthcare winstgroei	26.9%
Inkomstengroei	12.6%
Toekomstig rendement op eigen vermogen	11.4%
Dekking van analisten	Good
Laatst bijgewerkt	10 Oct 2024

Recente toekomstige groei-updates

Fortis Healthcare Limited (NSE:FORTIS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09

Fortis Healthcare Limited Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Feb 12

Recent updates

Returns Are Gaining Momentum At Fortis Healthcare (NSE:FORTIS)

Oct 04

The Price Is Right For Fortis Healthcare Limited (NSE:FORTIS)

Aug 27

Fortis Healthcare Limited (NSE:FORTIS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09

Fortis Healthcare (NSE:FORTIS) Shareholders Will Want The ROCE Trajectory To Continue

Mar 16

Fortis Healthcare Limited Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Feb 12

Shareholders Should Be Pleased With Fortis Healthcare Limited's (NSE:FORTIS) Price

Dec 31

Is Now The Time To Put Fortis Healthcare (NSE:FORTIS) On Your Watchlist?

Dec 16

Returns Are Gaining Momentum At Fortis Healthcare (NSE:FORTIS)

Nov 30

Does Fortis Healthcare (NSE:FORTIS) Have A Healthy Balance Sheet?

Sep 12

Here's Why Fortis Healthcare (NSE:FORTIS) Has Caught The Eye Of Investors

Aug 25

The Return Trends At Fortis Healthcare (NSE:FORTIS) Look Promising

Aug 10

These 4 Measures Indicate That Fortis Healthcare (NSE:FORTIS) Is Using Debt Reasonably Well

Jun 05

Fortis Healthcare (NSE:FORTIS) Seems To Use Debt Quite Sensibly

Jan 26

Here's Why Fortis Healthcare (NSE:FORTIS) Has Caught The Eye Of Investors

Dec 02

Fortis Healthcare Limited's (NSE:FORTIS) Shareholders Might Be Looking For Exit

Oct 19

Fortis Healthcare Limited's (NSE:FORTIS) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 07

Do Fortis Healthcare's (NSE:FORTIS) Earnings Warrant Your Attention?

Aug 23

Is Fortis Healthcare (NSE:FORTIS) Using Too Much Debt?

Jun 04

Fortis Healthcare Limited's (NSE:FORTIS) Intrinsic Value Is Potentially 26% Below Its Share Price

May 12

Here's Why Fortis Healthcare (NSE:FORTIS) Can Manage Its Debt Responsibly

Jan 09

Calculating The Fair Value Of Fortis Healthcare Limited (NSE:FORTIS)

Jul 23

Winst- en omzetgroeiprognoses

NSEI:FORTIS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (INR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	99,894	12,807	12,387	N/A	8
3/31/2026	89,813	10,266	9,915	N/A	15
3/31/2025	78,450	7,924	8,020	N/A	15
6/30/2024	70,944	6,531	N/A	N/A	N/A
3/31/2024	68,929	5,989	1,576	11,001	N/A
12/31/2023	67,497	5,527	N/A	N/A	N/A
9/30/2023	66,299	5,476	2,921	10,170	N/A
6/30/2023	64,672	5,782	N/A	N/A	N/A
3/31/2023	62,976	5,887	3,750	8,222	N/A
12/31/2022	60,330	5,241	N/A	N/A	N/A
9/30/2022	59,398	5,113	3,550	7,061	N/A
6/30/2022	57,952	4,138	N/A	N/A	N/A
3/31/2022	57,176	5,551	6,499	8,654	N/A
12/31/2021	55,920	5,303	N/A	N/A	N/A
9/30/2021	53,023	4,435	6,702	8,692	N/A
6/30/2021	48,345	3,327	N/A	N/A	N/A
3/31/2021	40,301	-1,098	2,670	4,855	N/A
12/31/2020	38,906	-1,974	N/A	N/A	N/A
9/30/2020	38,825	-3,037	-218	1,738	N/A
6/30/2020	41,000	-1,888	N/A	N/A	N/A
3/31/2020	46,323	579	157	1,715	N/A
12/31/2019	47,035	2,380	N/A	N/A	N/A
9/30/2019	46,379	1,173	N/A	N/A	N/A
6/30/2019	45,656	-1,604	N/A	N/A	N/A
3/31/2019	44,694	-2,989	-2,616	-1,785	N/A
12/31/2018	43,716	-13,666	N/A	N/A	N/A
9/30/2018	43,890	-12,062	N/A	N/A	N/A
6/30/2018	44,462	-10,853	N/A	N/A	N/A
3/31/2018	45,608	-10,092	N/A	4,929	N/A
12/31/2017	45,979	-1,450	N/A	N/A	N/A
9/30/2017	46,106	3,337	N/A	N/A	N/A
6/30/2017	46,092	4,108	N/A	N/A	N/A
3/31/2017	45,737	4,217	N/A	9,665	N/A
12/31/2016	45,334	3,453	N/A	N/A	N/A
9/30/2016	44,525	-1,267	N/A	N/A	N/A
6/30/2016	43,434	-1,028	N/A	N/A	N/A
3/31/2016	41,989	164	N/A	1,947	N/A
12/31/2015	40,775	736	N/A	N/A	N/A
9/30/2015	40,618	1,066	N/A	N/A	N/A
6/30/2015	39,963	145	N/A	N/A	N/A
3/31/2015	39,659	-1,186	N/A	241	N/A
12/31/2014	29,311	-5,867	N/A	N/A	N/A
9/30/2014	29,218	-1,754	N/A	N/A	N/A
6/30/2014	42,076	2,980	N/A	N/A	N/A
3/31/2014	34,919	-2,188	N/A	4,791	N/A
12/31/2013	36,197	744	N/A	N/A	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei FORTIS ( 24.1% per jaar) ligt boven de spaarquote ( 6.7% ).

Winst versus markt: De winst van FORTIS ( 24.1% per jaar) zal naar verwachting sneller groeien dan de Indian markt ( 17.9% per jaar).

Hoge groeiwinsten: De winst van FORTIS zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van FORTIS ( 12.6% per jaar) zal naar verwachting sneller groeien dan de markt Indian ( 10.3% per jaar).

Hoge groei-inkomsten: De omzet van FORTIS ( 12.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen FORTIS zal naar verwachting over 3 jaar laag zijn ( 11.4 %).

Fortis Healthcare Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Fortis Healthcare Limited (NSE:FORTIS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Price target increased by 7.9% to ₹521

Fortis Healthcare Limited Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Price target increased by 7.3% to ₹466

Consensus EPS estimates fall by 10%

Price target increased to ₹343

Recent updates

Returns Are Gaining Momentum At Fortis Healthcare (NSE:FORTIS)

The Price Is Right For Fortis Healthcare Limited (NSE:FORTIS)

Fortis Healthcare Reportedly to Buy Out PE Funds from Diagnostics Arm Agilus

Fortis Healthcare Limited (NSE:FORTIS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Fortis Healthcare Limited Announces Resignation of Ravi Rajagopal as Chairman and Non- Executive Independent Director, with Effect from Closing Hours on September 30, 2024

Fortis Healthcare's (NSE:FORTIS) Dividend Will Be ₹1.00

Upcoming dividend of ₹1.00 per share

Price target increased by 7.9% to ₹521

Full year 2024 earnings: EPS and revenues miss analyst expectations

Fortis Healthcare Limited to Report Q3, 2025 Results on Feb 14, 2025

Fortis Healthcare Limited Designates Prem Kumar Nair as Vice-Chairman of Board

Fortis Healthcare (NSE:FORTIS) Has Announced A Dividend Of ₹1.00

Dividend of ₹1.00 announced

Fortis Healthcare Limited, Annual General Meeting, Aug 02, 2024

Does Fortis Healthcare (NSE:FORTIS) Have A Healthy Balance Sheet?

Fortis Healthcare Limited Announces Executive Appointments

Fortis Healthcare Limited Recommends Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS and revenues miss analyst expectations

Fortis Healthcare Limited Recommends Final Dividend for the Financial Year 2023-24

Fortis Healthcare Limited to Report Q4, 2024 Results on May 23, 2024

Should You Be Adding Fortis Healthcare (NSE:FORTIS) To Your Watchlist Today?

Fortis Healthcare Limited's (NSE:FORTIS) Popularity With Investors Is Clear

Fortis Healthcare (NSE:FORTIS) Shareholders Will Want The ROCE Trajectory To Continue

Fortis Healthcare Limited Approves the Appointment of Sanjay Baweja as Chief Internal Audit and Risk Officer

Fortis Healthcare Limited Announces Change in Company Secretary and Compliance Office

Fortis Healthcare Limited Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next

Price target increased by 7.3% to ₹466

Fortis Healthcare Limited Appoints Bipin Kumar as Chief Information Officer

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Fortis Healthcare Limited to Report Q3, 2024 Results on Feb 07, 2024

Fortis Healthcare Limited Announces Resignation of Mayank Bhargava as Chief Information & Digital Officer

Shareholders Should Be Pleased With Fortis Healthcare Limited's (NSE:FORTIS) Price

Is Now The Time To Put Fortis Healthcare (NSE:FORTIS) On Your Watchlist?

High number of new directors

Returns Are Gaining Momentum At Fortis Healthcare (NSE:FORTIS)

Second quarter 2024 earnings released: EPS: ₹2.30 (vs ₹2.71 in 2Q 2023)

Consensus EPS estimates fall by 10%

Fortis Healthcare Limited Appoints Prem Kumar Nair as Additional Director (Non-Executive & Non-Independent)

Fortis Healthcare Limited to Report Q2, 2024 Results on Nov 10, 2023

Fortis Healthcare Limited Announces Resignation of Joerg Ayrle as Non- Executive & Non-Independent Director

High number of new directors

Fortis Healthcare Limited Appoints Ashok Pandit as an Additional Director

Does Fortis Healthcare (NSE:FORTIS) Have A Healthy Balance Sheet?

Fortis Healthcare Limited Announces Resignation of Heng Joo Joe Sim as Non-Executive & Non-Independent Director

Fortis Healthcare Limited Announces Resignation of Rajiv Puri as Head - Risk and Internal Audit

Fortis Healthcare Limited (NSEI:FORTIS) completed the acquisition of Medeor Hospital Manesar from Medeor Hospital Limited and VPS Health Care Private Limited.

Here's Why Fortis Healthcare (NSE:FORTIS) Has Caught The Eye Of Investors

The Return Trends At Fortis Healthcare (NSE:FORTIS) Look Promising

Fortis Healthcare Limited Declares Dividend for the Financial Year Ended March 31, 2023

Fortis Healthcare Limited to Report Q1, 2024 Results on Aug 04, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Fortis Healthcare Limited, Annual General Meeting, Aug 01, 2023

Sri Kauvery Medical Care (India) Limited entered into a business transfer agreement to acquire Arcot Road Business of Fortis Healthcare Limited (NSEI:FORTIS) for INR 1.5 billion.

These 4 Measures Indicate That Fortis Healthcare (NSE:FORTIS) Is Using Debt Reasonably Well

Full year 2023 earnings: EPS exceeds analyst expectations

Fortis Healthcare Limited Recommends A Final Dividend for the financial year 2022-23

Fortis Healthcare Limited Recommends A Final Dividend for the financial year 2022-23

Fortis Healthcare Limited Appoints Lim Tsin-Lin as Additional Director (Non-Executive & Non-Independent)

High number of new directors

Third quarter 2023 earnings released: EPS: ₹1.72 (vs ₹1.55 in 3Q 2022)

Fortis Healthcare (NSE:FORTIS) Seems To Use Debt Quite Sensibly

Here's Why Fortis Healthcare (NSE:FORTIS) Has Caught The Eye Of Investors

Price target increased to ₹343

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

High number of new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Fortis Healthcare Limited's (NSE:FORTIS) Shareholders Might Be Looking For Exit

Investor sentiment deteriorated over the past week

Fortis Healthcare Limited's (NSE:FORTIS) Intrinsic Value Is Potentially 20% Below Its Share Price